The Trade Development Authority of Pakistan hosted the first Pharma Stakeholders Dialogue at its Karachi headquarters on 14 November 2025, bringing together major pharmaceutical manufacturers and exporters, regulatory bodies, financial institutions and investors to chart a coordinated path for expanding Pakistan’s pharmaceutical export ecosystem. The meeting aimed to build consensus on priorities, market access strategies and financing mechanisms to scale exports.<\/p>\n
Sheryar Taj<\/strong>, Secretary TDAP, said the dialogue\u2019s purpose is to develop an inclusive roadmap for promoting Pakistan\u2019s pharmaceutical exports through consultation with all key stakeholders. He underlined Pakistan\u2019s rising potential in pharma exports and TDAP\u2019s role in supporting market access via global exhibitions, trade delegations and its flagship Health Engineering and Minerals Show.<\/p>\n Azhar Ali Dahar<\/strong>, Director General (E&M) TDAP, outlined facilitation measures and strategic efforts to open new export corridors for Pakistani pharmaceuticals. He highlighted recent export orders secured at the Made in Pakistan Expo in Ethiopia as a significant step under the Government\u2019s Look Africa Policy, reinforcing Pakistan\u2019s penetration into African markets. He stressed the need to strengthen footholds in less stringent and non\u2011traditional markets while also preparing a roadmap for SRA markets, coupled with possible financing models involving SBP, EXIM Bank, EDF and private investors to help exporters scale operations and meet global compliance.<\/p>\n Faiz Ahmad Chadhar<\/strong>, Chief Executive TDAP, reaffirmed the government\u2019s commitment to bolstering the pharmaceutical industry and noted increased liaison between government institutions and the private sector. He urged manufacturers to raise compliance standards and diversify beyond traditional destinations, pointing to improved product quality and growing readiness to enter higher\u2011value markets.<\/p>\n Participants agreed the dialogue will feed into a practical roadmap to promote pharma exports, combining market development, regulatory alignment and targeted financing support. TDAP signalled its intent to convert consensus into concrete initiatives that enable exporters to access new corridors, meet international standards and capture emerging opportunities abroad.<\/p>\n","protected":false},"excerpt":{"rendered":" TDAP convenes industry, regulators and financiers on 14 November to accelerate pharma exports with a unified roadmap and financing pathways.<\/p>\n","protected":false},"author":7,"featured_media":14155,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[94],"tags":[],"class_list":["post-14156","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pakistan"],"_links":{"self":[{"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/posts\/14156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/comments?post=14156"}],"version-history":[{"count":0,"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/posts\/14156\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/media\/14155"}],"wp:attachment":[{"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/media?parent=14156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/categories?post=14156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.peakpoint.pk\/en\/wp-json\/wp\/v2\/tags?post=14156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}